[HTML][HTML] The role of phosphate in kidney disease

MG Vervloet, S Sezer, ZA Massy, L Johansson… - Nature Reviews …, 2017 - nature.com
The importance of phosphate homeostasis in chronic kidney disease (CKD) has been
recognized for decades, but novel insights—which are frequently relevant to everyday …

Vegetable-based diets for chronic kidney disease? It is time to reconsider

A Cases, S Cigarrán-Guldrís, S Mas, E Gonzalez-Parra - Nutrients, 2019 - mdpi.com
Traditional dietary recommendations to renal patients limited the intake of fruits and
vegetables because of their high potassium content. However, this paradigm is rapidly …

Diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder: Synopsis of the kidney disease: improving global outcomes …

M Ketteler, GA Block, P Evenepoel… - Annals of internal …, 2018 - acpjournals.org
Description: The Kidney Disease: Improving Global Outcomes (KDIGO) 2017 Clinical
Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of …

[PDF][PDF] Clinical practice guideline for the management of chronic kidney disease‐mineral and bone disorder

M Fukagawa, K Yokoyama, F Koiwa… - … Apheresis and Dialysis, 2013 - jsdt.or.jp
Masafumi Fukagawa, 1 Keitaro Yokoyama, 1 Fumihiko Koiwa, 1 Masatomo Taniguchi, 1
Tetsuo Shoji, 1 Junichiro James Kazama, 1 Hirotaka Komaba, 1 Ryoichi Ando, 1 Takatoshi …

Phosphate as a signaling molecule and its sensing mechanism

T Michigami, M Kawai, M Yamazaki… - Physiological …, 2018 - journals.physiology.org
In mammals, phosphate balance is maintained by influx and efflux via the intestines,
kidneys, bone, and soft tissue, which involves multiple sodium/phosphate (Na+/Pi) …

Fibroblast growth factor 23 and Inflammation in CKD

JM Mendoza, T Isakova, AC Ricardo… - Clinical Journal of the …, 2012 - journals.lww.com
Results FGF23 correlated directly with IL-6 (r= 0.4), CRP (r= 0.2), TNF-α (r= 0.4), and
fibrinogen (r= 0.3; P< 0.001 for each). In univariate and multivariable-adjusted linear …

[HTML][HTML] Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease

JJ Scialla, M Wolf - Nature Reviews Nephrology, 2014 - nature.com
Disturbances in phosphate homeostasis are common in patients with chronic kidney
disease. As kidney function declines, circulating concentrations of phosphate and the …

Joint modelling of repeated measurement and time-to-event data: an introductory tutorial

Ö Asar, J Ritchie, PA Kalra… - International journal of …, 2015 - academic.oup.com
Backgound: The term 'joint modelling'is used in the statistical literature to refer to methods for
simultaneously analysing longitudinal measurement outcomes, also called repeated …

[HTML][HTML] Treatment of chronic kidney disease

JM Turner, C Bauer, MK Abramowitz, ML Melamed… - Kidney international, 2012 - Elsevier
Treatment of chronic kidney disease (CKD) can slow its progression to end-stage renal
disease (ESRD). However, the therapies remain limited. Blood pressure control using …

Efficacy and safety of tenapanor in patients with hyperphosphatemia receiving maintenance hemodialysis: a randomized phase 3 trial

GA Block, DP Rosenbaum, A Yan… - Journal of the American …, 2019 - journals.lww.com
Background Guidelines recommend reducing elevated serum phosphate in patients with
CKD. Tenapanor, a minimally absorbed inhibitor of gastrointestinal sodium/hydrogen …